Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Clinical Trajectories in Patients with Severe Acute Brain Injury Requiring Mechanical Ventilation: A Descriptive Analysis of a Single-Center Prospective Observational Cohort Study
Neuro Trauma and Critical Care
P5 - Poster Session 5 (11:45 AM-12:45 PM)
1-005
Patients with SABI often require MV due to impaired consciousness and insufficient airway protection, reflecting a substantial neurological injury. Outcomes for this high-acuity population have been insufficiently explored.
To describe outcomes for patients with severe acute brain injury (SABI) who require mechanical ventilation (MV).
In this single-center prospective, observational cohort study at a level-1 trauma and comprehensive stroke center, we included consecutive adult patients with SABI, including traumatic brain injury (TBI), spontaneous intracranial hemorrhage (sICH), acute ischemic stroke (AIS), and subarachnoid hemorrhage (SAH), who required MV on admission between September-November 2021. We assessed in-hospital and 6-12 months mortality, tracheostomy and percutaneous gastrostomy tube (PEG) placement, and Extended Glasgow Outcome Score (GOS-E) at 6-12 months.
Overall, 90 patients (age 55 [SD 19], 73% male; median Glasgow Coma Scale on admission 7 [IQR 3,11]; 50% TBI, 20% sICH, 18% AIS, 12% SAH) were included. Median duration of MV was 2 days (IQR 1,7), with 40% requiring MV for £ 24 hours (G1), 37% 1-7 days (G2), and 23% >7 days (G3).  In-hospital mortality was 47% (n=42), 79% (33/42) died after withdrawal of life-sustaining treatments (30% £24 hours, 24% 1-7 days, 45% >7 days). One third of survivors (30%, n=13) underwent PEG, 16% (n=7) tracheostomy. At 6-12 months, 51% (n=46) had died (51% TBI, 67% sICH, 44% AIS, 36% SAH; 44% G1, 55% G2, 57% G3); 57% of survivors (64% TBI, 50% sICH, 33% AIS, 71% SAH; 60% G1, 67% G2, 22% G3) had a GOS-E of 5-8. Among survivors who underwent PEG and tracheostomy, 54% and 29% had a GOS-E 5-8; all survivors who initially underwent tracheostomy were decannulated at 6-12 months.
Mortality and long-term disability in patients with SABI who required MV were high and varied based on SABI subtype and duration of MV. 
Authors/Disclosures
Natalie Smith
PRESENTER
Ms. Smith has nothing to disclose.
Adrienne James (University of Washington) Ms. JAMES has nothing to disclose.
Nassim Matin, MD (Barrow Neurological Institute) Dr. Matin has nothing to disclose.
Kasra Sarhadi, MD Dr. Sarhadi has nothing to disclose.
James A. Town, MD (Harborview Medical Center) Dr. Town has nothing to disclose.
Claire Creutzfeldt, MD The institution of Dr. Creutzfeldt has received research support from NINDS. The institution of Dr. Creutzfeldt has received research support from NINR.
Chiara Robba No disclosure on file
Giuseppe Citerio No disclosure on file
Abhijit Lele, MD,MBBS,Other Dr. Lele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LifeCenter Northwest .
Sarah Wahlster, MD Dr. Wahlster has nothing to disclose.